Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Jai Won Chang"'
Autor:
Chan-Young Jung, Jai Won Chang
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss 4, Pp 891-908 (2023)
Hepatorenal syndrome (HRS), a progressive but potentially reversible deterioration of kidney function, remains a major complication in patients with advanced cirrhosis, often leading to death before liver transplantation (LT). Recent updates in the p
Externí odkaz:
https://doaj.org/article/7e9e93006a6c4ed0b2468b643cee694a
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background There are limited data focusing specifically on the types of arteriovenous (AV) access used and outcomes of AV access among cancer patients as a consequence of cancer. We aimed to describe outcomes of AV access among cancer patien
Externí odkaz:
https://doaj.org/article/6ae3b3a7335a4f668ad984115eb99b1f
Autor:
Seonjeong Jeong, Hyunwook Kwon, Jai Won Chang, Min-Ju Kim, Khaliun Ganbold, Youngjin Han, Tae-Won Kwon, Yong-Pil Cho
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background In this single-center, retrospective observational study, we assessed the long-term patency of vascular access (VA) after first VA placement to uncover independent risk factors associated with VA patency in Asian hemodialysis (HD)
Externí odkaz:
https://doaj.org/article/8e5cd376e9e147bb8813038459bf9f7f
Autor:
Seonjeong Jeong, Gi Byoung Nam, Jai Won Chang, Min-Ju Kim, Youngjin Han, Tae-Won Kwon, Yong-Pil Cho
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background We investigated the impact of a transvenous cardiac implantable electronic device (CIED) placement on outcomes and arteriovenous vascular access (VA) patency among chronic hemodialysis patients. Methods This is a single-center, ob
Externí odkaz:
https://doaj.org/article/d1ad55ba062d45b69a0b347cff9040f7
Autor:
Seung Don Baek, Jae-Young Kang, Hoon Yu, Seulgi Shin, Hyang-Sook Park, Mi-Soon Kim, Eun Kyoung Lee, So Mi Kim, Jai Won Chang
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background Evidence suggests that alkaline phosphatase attenuates inflammatory response in sepsis by lipopolysaccharide detoxification and adenosine triphosphate dephosphorylation. We sought to determine changes in alkaline phosphatase (AP)
Externí odkaz:
https://doaj.org/article/cc6fd6070cb444e48604f8c331082c3e
Publikováno v:
Kidney Research and Clinical Practice, Vol 36, Iss 3, Pp 290-295 (2017)
Background: Volume overload results in higher mortality rates in patients on continuous ambulatory peritoneal dialysis (CAPD). The ratio of bioimpedance (RBI) might be a helpful parameter in adjusting dry body weight in CAPD patients. This study exam
Externí odkaz:
https://doaj.org/article/011598157fd24b48bdcb34580ef0758d
Autor:
Seonjeong Jeong, Hyunwook Kwon, Jai Won Chang, Min-Ju Kim, Khaliun Ganbold, Youngjin Han, Tae-Won Kwon, Yong-Pil Cho
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0211296 (2019)
In an incident hemodialysis (HD) population, we aimed to investigate whether arteriovenous fistula (AVF) creation before HD initiation was associated with improved AVF patency compared with AVF creation from a central venous catheter (CVC), and also
Externí odkaz:
https://doaj.org/article/b2ee408b076f4b199cce2b0bc2ecd9ea
Publikováno v:
Nutrients, Vol 9, Iss 4, p 399 (2017)
Protein-energy wasting (PEW) is associated with mortality in patients with end-stage renal disease (ESRD) on maintenance hemodialysis. The correct diagnosis of PEW is extremely important in order to predict clinical outcomes. However, it is unclear w
Externí odkaz:
https://doaj.org/article/edabdfd8bcf3474791e60f26f9da7d1c
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 2, p 305 (2017)
Endoplasmic reticulum (ER) stress is increasingly identified as modulator of fibrosis. Losartan, an angiotensin II receptor blocker, has been widely used as the first choice of treatment in chronic renal diseases. We postulated that anti-fibrotic eff
Externí odkaz:
https://doaj.org/article/91ed9f2d08a54dc3b127c5a9db60eb77
Autor:
Kyung Sun Park, Jai Won Chang
Publikováno v:
Kidney Research and Clinical Practice, Vol 31, Iss 2, p A65 (2012)
Correction of hyperuricemia can slow down the progression of renal disease in animal study. However, there is limited data regarding the effect of lowering serum uric acid in patients with hyperuricemic chronic kidney disease (CKD) stage 3 (estimated
Externí odkaz:
https://doaj.org/article/79dbc9f98c8e4791aa9745e5dc175620